《大行報告》中金:恆指公司2月中公布半年檢 料京東健康、飛鶴及中芯或「染藍」
中金發表報告表示,恆生指數公司2月18日收市後(3月7日執行)公布恆生系列指數半年度審議結果,其中包括恆生指數、國企指數、恆生科技指數等港股主要旗艦指數,以及作為港股通樣本基礎的恆生綜合指數。由於此次為半年度調整且恆指的系統性優化正在途中,因此預計涉及到的調整幅度較大。
該行指考慮到追蹤部分旗艦指數的被動資金規模大(據彭博資訊統計,追蹤恆指與國企指數的ETF資金規模分別約為219億美元和46.5億美元),該行認為潛在成分股變動以及相應帶來資金流向的變化值得投資者重點關注。基於現有可得公開數據,料恆生指數半年度調整,指數擴容步伐或將加快。
該行估算京東健康(06618.HK)、思摩爾國際(06969.HK)、農夫山泉(09633.HK)、翰森製藥(03692.HK)、中國飛鶴(06186.HK)、中升控股(00881.HK)、中芯國際(00981.HK)、中國燃氣(00384.HK)等排在恆生指數順位前列,有可能成為被納入的潛在候選者。該行的測算優先考慮市值順位,同時結合各行業代表性綜合考量得到。
根據恆指公司2021年3月發布的優化建議,恆生指數成分股將在2022年中前增加至80隻,最終固定在100隻。考慮到當前距離2022年年中前僅有此次半年度調整、以3月31日和6月30日為考察截止日期的兩次調整,因此該行預計此次擴容步伐可能相較前幾次更顯著(2021年首季度增加3隻、2季度增加2隻、3季度增加4隻)。隨著成分股擴容,部分行業的覆蓋度也將隨之而擴大。
此次恆生綜合指數半年度調整,將影響港股通投資範圍,中金料或共有15隻股票符合納入港股通的標準,包括小鵬汽車-W(09868.HK)、東方海外(00316.HK)、保利協鑫(03800.HK)、微創機器人-B(02252.HK)、雲音樂(09899.HK)、聯合能源集團(00467.HK)、力勁科技(00558.HK)、金陽新能源(01121.HK)、三葉草生物-B(02197.HK)、鼎豐集團控股(06878.HK)、中國有色礦業(01258.HK)、醫思健康(02138.HK)、榮暉國際(00990.HK)、安能物流(09956.HK)和康諾亞-B(02162.HK)。(wl/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.